New York Genome Center

@nygenome.org

An independent, nonprofit academic research institution at the forefront of transforming biomedical research to advance genomic science and precision medicine.

We're proud to share this important work, with contributions from NYGC scientists, Nicolas Robine, William Hooper, Tim Chu, and Jennifer Shelton. This transformative resource will help advance cancer research and accelerate scientific discovery @nicorobine.bsky.social x.com/CSHL/status/...

Cold Spring Harbor Laboratory (@CSHL) on X

The next generation of cancer research models has arrived. An international consortium led by CSHL and @NorthwellHealth has developed more than 150 organoid models representing actual patient tumors s...

x.com

Today in @cellcellpress.bsky.social Dr. Hemali Phatnani and collaborators show different forms of cognitive impairment in ALS arise from biological processes, providing a new framework for understanding the disease and developing more precise therapies. Read more: www.nygenome.org/news-events/...

New Study Reveals Distinct Biological Drivers of Cognitive Impairment in ALS - August 4, 2026

Read about New Study Reveals Distinct Biological Drivers of Cognitive Impairment in ALS at the New York Genome Center on August 4, 2026

nygenome.org

Exciting to see this NIH-funded research highlighted by NIH Director Jay Bhattacharya, MD, PhD Congratulations to Bing Ren and collaborators on this important discovery—a major step forward in understanding how brain aging may contribute to neurodegenerative disease. x.com/NIHDirector_...

Jay Bhattacharya, MD, PhD (@NIHDirector_Jay) on X

🧠New NIH-funded research has uncovered an aspect of human brain aging that reshapes our approach to age-related cognitive decline and dementia risk. This knowledge will be critical as we work toward ...

x.com

A new @science.org study co-led by NYGC CEO & Scientific Director Dr. Bing Ren provides the first comprehensive single-cell map of gene regulation in failing human hearts, revealing new therapeutic targets for heart failure. Read more: www.nygenome.org/news-events/...

Gene Regulation Map Reveals Treatment Targets for Heart Failure - July 27, 2026

Read about Gene Regulation Map Reveals Treatment Targets for Heart Failure at the New York Genome Center on July 27, 2026

nygenome.org

Nothing brings people together like the World Cup! ⚽️ Thanks to NYGC’s HR Team and Employee Engagement Group for organizing a fun social hour filled with soccer, snacks, and great company!

BildBildBild

A new study using laboratory technology reveals the inner workings of how a type of brain tumor progresses toward greater malignancy. NYGC Core Faculty @landau.bsky.social led this research with colleagues at Harvard Medical School and Mass General Brigham. Article: www.nygenome.org/news-events/...

Cancer Evolution Study Reveals Biology of Glioma Progression - July 10, 2026

Read about Cancer Evolution Study Reveals Biology of Glioma Progression at the New York Genome Center on July 10, 2026

nygenome.org

Please join us in welcoming our 2026 summer interns! Program highlights include mentorship, lab tours, scientific seminars, career development workshops, a poster session and much more!

Bild

Congratulations to NYGC Core Faculty Member, Sanja Vicković, PhD on receiving an NIH R01 grant from the National Human Genome Research Institute to develop a cost-accessible platform for spatial multi-omic profiling Read more: www.nygenome.org/news-events/...

New York Genome Center aims to lower barriers to spatial multi-omics with NIH funding - July 1, 2026

Read about New York Genome Center aims to lower barriers to spatial multi-omics with NIH funding at the New York Genome Center on July 1, 2026

nygenome.org

Congratulations @landau.bsky.social, breakthrough technology from the lab, now live in @cellcellpress.bsky.social Instead of cutting the genome where proteins bind (e.g., Cut&Tag), D&D-seq scars the DNA with a deaminase, allowing single cell genome mapping of TFs and chromatin remodellers!

Dan Landau@landau.bsky.social · 2mo ago

Check out full text here: www.cell.com/cell/fulltex... Congrats to Wei-Yu, Sang-Ho @ivanraimondi.bsky.social and the whole team! Gratitude to @themarkfdn.bsky.social @cegs-ica.bsky.social @smahtnetwrk.bsky.social

@nevillesanjana.bsky.social Core Faculty Member of the New York Genome Center, explains how scalable CRISPR screens + single-cell sequencing are helping connect noncoding variants to disease biology and therapeutic targets. Read more; www.nygenome.org/news-events/...

Turning GWAS signals into drug targets with scalable CRISPR - May 26, 2026

Read about Turning GWAS signals into drug targets with scalable CRISPR at the New York Genome Center on May 26, 2026

nygenome.org

⚠️Preprint alert⚠️: we set up Polyethnic-1000 at @nygenome.org to study the molecular basis of cancer disparities. One striking example is endometrial cancer, with much higher mortality in patients of African ancestry.

bioRxivpreprint@biorxivpreprint.bsky.social · 3mo ago

Comprehensive Molecular Characterization of High-Grade Endometrial Cancer in an Ancestrally-Diverse Cohort https://www.biorxiv.org/content/10.64898/2026.05.01.721962v1